Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rao, G.
Right arrow Articles by Rameshwar, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, G.
Right arrow Articles by Rameshwar, P.
[Cancer Research 64, 2874-2881, April 15, 2004]
© 2004 American Association for Cancer Research


Immunology

Facilitating Role of Preprotachykinin-I Gene in the Integration of Breast Cancer Cells within the Stromal Compartment of the Bone Marrow

A Model of Early Cancer Progression

Gayatri Rao1, Prem S. Patel2, Suji P. Idler1, Paul Maloof1, Pedro Gascon3, Julius A. Potian1 and Pranela Rameshwar1

1 Department of Medicine–Hematology/Oncology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, New Jersey; 2 Department of Surgery, Brookdale University Hospital and Medical Center, Brooklyn, New York; and 3 Hospital Clinic, ICMHO, IDIBAPS, Barcelona, Spain

Despite early detection of breast cancer, patients’ survival may be compromised if the breast cancer cells (BCCs) enter the bone marrow (BM). It is highly probable that BCCs enter the BM long before clinical detection. An in vitro coculture model with BM stroma and BCCs (cell lines; primary cells from stage III BC, n = 7, and stage M0, n = 3) mimicked early entry of BCCs into the BM. In coculture, BCCs exhibit contact inhibition and do not require otherwise needed growth supplements. Stromal growth rate was increased 2-fold in coculture. The inclusion of BCCs in stromal support of long-term culture-initiating cell assay frequencies show no difference (38 ± 3 versus 36 ± 6). Nontumorigenic breast cells (patients and cell lines) did not survive in coculture, suggesting that the model could select for malignant population in surgical breast tissues. Cocultures were able to select cells with 73 ± 7% cloning efficiencies and with the ability to form cocultures with BM stroma. Preprotachykinin-I (PPT-I), a gene that is conserved by evolution, facilitates BCC integration as part of the stromal compartment. This was deduced as follows: (a) nontumorigenic breast cells (n = 4) genetically engineered to express PPT-I and led to anchorage-independent growth, foci formation, and formation of cocultures; and (b) suppression of PPT-I in BCCs (n = 5) with pPMSKH1-PPT-I small interfering RNA reverted the cells to nontumorigenic phenotypes and was undetectable in the BM nude mice. The evidence supports that the PPT-I gene facilitates the integration of BCCs in the stromal compartment during a period before clinical detection, without disrupting hematopoietic activity.




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
K. E Corcoran, A. Malhotra, C. A Molina, and P. Rameshwar
Stromal-derived factor-1{alpha} induces a non-canonical pathway to activate the endocrine-linked Tac1 gene in non-tumorigenic breast cells
J. Mol. Endocrinol., March 1, 2008; 40(3): 113 - 123.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Greco, S. V. Smirnov, R. G. Murthy, and P. Rameshwar
Synergy between the RE-1 Silencer of Transcription and NF{kappa}B in the Repression of the Neurotransmitter Gene TAC1 in Human Mesenchymal Stem Cells
J. Biol. Chem., October 12, 2007; 282(41): 30039 - 30050.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. H. Ramkissoon, P. S. Patel, M. Taborga, and P. Rameshwar
Nuclear Factor-{kappa}B Is Central to the Expression of Truncated Neurokinin-1 Receptor in Breast Cancer: Implication for Breast Cancer Cell Quiescence within Bone Marrow Stroma
Cancer Res., February 15, 2007; 67(4): 1653 - 1659.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. L. Moharita, M. Taborga, K. E. Corcoran, M. Bryan, P. S. Patel, and P. Rameshwar
SDF-1{alpha} regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis
Blood, November 15, 2006; 108(10): 3245 - 3252.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. J. Patel, S. H. Ramkissoon, P. S. Patel, and P. Rameshwar
Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides
PNAS, November 29, 2005; 102(48): 17436 - 17441.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. S. Oh, A. Moharita, J. G. Potian, I. P. Whitehead, J. C. Livingston, T. A. Castro, P. S. Patel, and P. Rameshwar
Bone Marrow Stroma Influences Transforming Growth Factor-{beta} Production in Breast Cancer Cells to Regulate c-myc Activation of the Preprotachykinin-I Gene in Breast Cancer Cells
Cancer Res., September 1, 2004; 64(17): 6327 - 6336.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.